KPTI 8-K 2026-10-14

Karyopharm Therapeutics Inc. (KPTI) 8-K dated 2026-10-14 — accession 0001193125-26-421025. This URL is the filing, not the KPTI hub.

Karyopharm Therapeutics Inc. (KPTI) is a biotechnology company listed on US.

Karyopharm Therapeutics Inc. filed a 8-K on 2026-10-14. Accession 0001193125-26-421025.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported KPTI revenue for 2025-12-31 was $146.1M. Net income was -$196.0M. Revenue was up 0.6% from 2024-12-31 to 2025-12-31. KPTI currently screens at market cap $205.6M.

Not investment advice. The KPTI SEC hub lists recent forms. The stock page is the research view.